000 | 01519 a2200505 4500 | ||
---|---|---|---|
005 | 20250512220558.0 | ||
264 | 0 | _c19850226 | |
008 | 198502s 0 0 eng d | ||
022 | _a0162-0886 | ||
024 | 7 |
_a10.1093/clinids/6.supplement_4.s821 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNightingale, C H | |
245 | 0 | 0 |
_aTissue penetration and half-life of cefonicid. _h[electronic resource] |
260 |
_bReviews of infectious diseases _c |
||
300 |
_aS821-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aCardiac Surgical Procedures |
650 | 0 | 4 |
_aCefamandole _xanalogs & derivatives |
650 | 0 | 4 |
_aCefazolin _xmetabolism |
650 | 0 | 4 | _aCefonicid |
650 | 0 | 4 |
_aCefoxitin _xmetabolism |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHip Prosthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHysterectomy |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPremedication |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTissue Distribution |
700 | 1 | _aQuintiliani, R | |
700 | 1 | _aDudley, M N | |
700 | 1 | _aGough, P | |
700 | 1 | _aHickingbotham, M | |
700 | 1 | _aJordan, N S | |
700 | 1 | _aRose, D | |
700 | 1 | _aToscani, M | |
773 | 0 |
_tReviews of infectious diseases _gvol. 6 Suppl 4 _gp. S821-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/clinids/6.supplement_4.s821 _zAvailable from publisher's website |
999 |
_c6522804 _d6522804 |